Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
G. Lopez‐Berestein(The University of Texas MD Anderson Cancer Center), G. P. Bodey(The University of Texas MD Anderson Cancer Center), Rohtesh S. Mehta(The University of Texas MD Anderson Cancer Center), James M. Reuben(The University of Texas at San Antonio Health Science Center), R. L. Juliano(The University of Texas MD Anderson Cancer Center), Roy L. Hopfer(The University of Texas MD Anderson Cancer Center), E. M. Hersh(The University of Texas MD Anderson Cancer Center), Victor Fainstein, Mario A. Luna(The University of Texas MD Anderson Cancer Center), M Keating(The University of Texas MD Anderson Cancer Center), K. Mehta(The University of Texas MD Anderson Cancer Center), Michael G. Rosenblum(Target (United States)), M. P. Sullivan(The University of Texas MD Anderson Cancer Center)
Cited by 408
Related Papers
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
|Journal of Clinical Oncology|2001|610
Pseudomonas bacteremia. Retrospective analysis of 410 episodes
|Archives of Internal Medicine|1985|361
Systemic candidiasis in cancer patients.
|PubMed|1984|272
Recent Experience With Pseudomonas aeruginosa Bacteremia in Patients With Cancer
|Archives of Internal Medicine|2000|238